HD Tirsema 44 Advanced Metabolic Hybrid Research Pen Dual-Compound Peptide Complex

HD Lab Tirsema Contains: GLP-1 & GIP-related research compounds (4mg Semaglutide/ 40mg Tirzepatide)

Product Overview

The Advanced Metabolic Hybrid Research Pen is a dual-compound peptide formulation supplied in a precision pen format for laboratory and metabolic pathway research.

This formulation combines two widely studied incretin-related research compounds commonly referenced in scientific literature exploring appetite signaling, insulin pathways, and metabolic regulation mechanisms.

Compound Information (Research Context)

This hybrid formulation contains:

GLP-1–related research compound

Dual incretin (GIP/GLP-1) pathway research compound

These compounds are frequently studied together in research settings to better understand:

Appetite and satiety signalling pathways

Glucose regulation mechanisms

Energy balance and metabolic efficiency

Hormonal communication involved in weight regulation

Research Use & Format

Precision prefilled pen format

Designed for controlled compound handling

Intended for laboratory, analytical, and educational research

Not intended for personal, cosmetic, or therapeutic use

Intended Audience

This product is intended for research professionals, laboratories, and experienced compound handlers familiar with peptide research protocols.

Primary Disclaimer

This product is not intended to diagnose, treat, cure, or prevent any disease.

Research Disclaimer

All peptide products are sold strictly for laboratory and research purposes only.
No medical, therapeutic, or weight-loss outcomes are claimed or implied.